Skip to main content
Jacob Lalezari, MD, Internal Medicine, San Francisco, CA, California Pacific Medical Center

JacobLalezariMD

Internal Medicine • San Francisco, CA

Physician

Join to view full profile

Dr. Lalezari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lalezari's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)/Mount Zion
    University of California (San Francisco)/Mount ZionResidency, Internal Medicine, 1986 - 1989
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1986

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - 2025
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Remarkable Turnaround Following Leronlimab Treatment in Critically Ill COVID-19 Patient After 84 Days on ECMO; Case Study Published in Journal of Translational Autoimmunity
    Remarkable Turnaround Following Leronlimab Treatment in Critically Ill COVID-19 Patient After 84 Days on ECMO; Case Study Published in Journal of Translational AutoimmunityMarch 29th, 2021
  • CytoDyn to Hold Webcast on October 20 to Discuss DSMC's Recommendations from the Interim Analysis of the Phase 2b/3 Clinical Trial for Severe-to-Critical COVID-19 Patients
    CytoDyn to Hold Webcast on October 20 to Discuss DSMC's Recommendations from the Interim Analysis of the Phase 2b/3 Clinical Trial for Severe-to-Critical COVID-19 PatientsOctober 17th, 2020
  • CytoDyn to Hold Conference Call on September 16 to Provide Update on Discussions with FDA and MHRA for COVID-19 and FDA Meeting on BLA Filing
    CytoDyn to Hold Conference Call on September 16 to Provide Update on Discussions with FDA and MHRA for COVID-19 and FDA Meeting on BLA FilingSeptember 10th, 2020
  • Join now to see all

Hospital Affiliations

Dr. Jacob Lalezari, Dr. Jacob Lalezari, MD, Dr. J Lalezari